Featured Jobs
|
Pentegra
|
|
Compass
|
|
BPAS
|
|
Mergers & Acquisition Specialist Compass
|
|
Automotive Industries Trust Funds
|
|
Strongpoint Partners
|
|
The Pension Source
|
|
Retirement Plan Onboarding Specialist Compass
|
|
BPAS
|
|
Nova 401(k) Associates
|
|
Attorney - ERISA, Benefits, & PRT Securian Financial Group
|
|
Independent Retirement
|
|
Combo Retirement Plan Administrator Strongpoint Partners
|
|
Relationship Manager for Defined Benefit/Cash Balance Plans MM Daybright Financial
|
|
Senior Client Service Specialist EPIC RPS
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
Novo, Lilly to Sell Obesity Drugs Directly to Employers
Seeking Alpha; login may be required 
Nov. 21, 2025 "Starting from Jan. 1, the pharma giants will offer their obesity drugs Wegovy and Zepbound through Waltz Health, a digital health company focused on helping employers buy affordable medications. Under the offering, employers will procure the injectables by paying upfront, fixed prices without involving rebates and fees, which are usually paid to PBMs as part of traditional drug purchases." MORE >> |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |